Insulet's average Accounts Receivable for the
three
months ended in Mar. 2025 was $375 Mil. Insulet's Revenue for the
three
months ended in Mar. 2025 was $569 Mil.
Hence, Insulet's Days Sales Outstanding for the
three
months ended in Mar. 2025 was 60.11.
The historical rank and industry rank for Insulet's Days Sales Outstanding or its related term are showing as below:
PODD'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 32.34 Med: 40.17 Max: 62.87
Current: 59.57
During the past 13 years, Insulet's highest Days Sales Outstanding was 62.87. The lowest was 32.34. And the median was 40.17.
PODD's Days Sales Outstanding is ranked better than 57.65% of 810
companies
in the Medical Devices & Instruments industry
Industry Median: 65.905
vs PODD: 59.57
Insulet's Days Sales Outstanding
declined
from Mar. 2024 (69.93) to Mar. 2025 (60.11).
Insulet Days Sales Outstanding Historical Data
The historical data trend for Insulet's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Insulet's Days Sales Outstanding
For the Medical Devices subindustry, Insulet's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Insulet's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Insulet's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Insulet's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Insulet (NAS:PODD) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Insulet Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Insulet's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PODD has been successfully added to your 